Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent for adult T-cell
leukemia/lymphoma (ATL). 1–3 Only a small proportion of HTLV-1 carriers eventually …

Previously we reported that asymptomatic human T-cell lymphotropic virus type 1 (HTLV-1)
carriers with a monoclonal proliferation of HTLV-1–infected T cells (“pre–adult T-cell …

Adult T‐cell leukemia/lymphoma (ATL), a malignancy of mature CD4‐positive lymphocytes,
has been etiologically linked to the human retrovirus HTLV‐I. Although a long latent period …

Highlights•Molecular mechanisms of HTLV-1 oncogenesis.•Innate and acquired immune
response to HTLV-1.•Clonality of HTLV-1 in vivo.•We bring together the host and viral factors …

Human T-cell leukemia virus type 1 (HTLV-1) is a complex human delta retrovirus that
infects an estimated 10–20 million people worldwide (Gessain and Cassar 2012). HTLV-1 …

Human T-cell lymphotropic virus type-1 (HTLV-1) is aetiologically associated with adult T-
cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant …

Most previous studies aimed at estimating the number of human T‐cell leukemia virus type‐
1 (HTLV‐1) carriers in endemic areas have been based on seroprevalence rates in blood …

Definitive risk factors for the development of adult T-cell leukemia (ATL) among
asymptomatic human T-cell leukemia virus type I (HTLV-1) carriers remain unclear …

The level of proviral DNA in peripheral blood mononuclear cells from a representative group
of asymptomatic HTLV‐I carriers in Miyazaki district, an HTLV‐I endemic area in Japan, was …

Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive peripheral T-cell malignancy
that develops after long-term chronic infection with human T-cell lymphotropic virus type-1 …